In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended…
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…
Genesis Electrified GV70 awarded Premium Car of the Year at Scottish Car of the Year Awards 2025The win marks the…
Updated cancer treatment guidelines reflect significant progress in cancer care delivery through ongoing collaborative efforts to strengthen oncology resources across…
2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from the U.S. Insurance Institute for Highway Safety (IIHS)Result…
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…
23 October 2025 - An updated analysis of venues shows that 86 per cent of all permanent venues used at the…
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase 1/2 RAINFOL™-01 trial showed rinatabart sesutecan (Rina-S®) 100…
LAS VEGAS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Bitcoin…